Abivax SA American Depositary Shares (ABVX) News
Latest headlines that mention ABVX, newest first · each headline opens the original publisher
- Last price
- $86.50
- Day change
- -1.72%
- Next earnings
- —
ABVX headlines
latest coverageNot much coverage yet. ABVX has appeared in only a few headlines lately; new stories show up here as publishers cover it.
Its latest fundraising round provides the French biotech with enough cash to finance operations through 2029.
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
ABVX news alerts
Get an alert by email or push when a new headline mentions ABVX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.